CN114344183A - Oil Control Composition (OCC), preparation method thereof, and skin care product and shampoo containing same - Google Patents
Oil Control Composition (OCC), preparation method thereof, and skin care product and shampoo containing same Download PDFInfo
- Publication number
- CN114344183A CN114344183A CN202111340294.9A CN202111340294A CN114344183A CN 114344183 A CN114344183 A CN 114344183A CN 202111340294 A CN202111340294 A CN 202111340294A CN 114344183 A CN114344183 A CN 114344183A
- Authority
- CN
- China
- Prior art keywords
- extract
- oil control
- control composition
- pericarp
- 3bark
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 71
- 239000002453 shampoo Substances 0.000 title claims abstract description 12
- 238000002360 preparation method Methods 0.000 title abstract description 7
- 239000000284 extract Substances 0.000 claims abstract description 58
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 46
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 28
- 235000014360 Punica granatum Nutrition 0.000 claims abstract description 21
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000011701 zinc Substances 0.000 claims abstract description 19
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 19
- 238000003756 stirring Methods 0.000 claims abstract description 18
- 229940015975 1,2-hexanediol Drugs 0.000 claims abstract description 15
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims abstract description 15
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229960005323 phenoxyethanol Drugs 0.000 claims abstract description 15
- 229940059958 centella asiatica extract Drugs 0.000 claims abstract description 12
- 240000006053 Garcinia mangostana Species 0.000 claims abstract description 10
- 235000017048 Garcinia mangostana Nutrition 0.000 claims abstract description 10
- 241001673966 Magnolia officinalis Species 0.000 claims abstract description 6
- 238000002156 mixing Methods 0.000 claims abstract description 4
- 241000167550 Centella Species 0.000 claims abstract description 3
- 244000269722 Thea sinensis Species 0.000 claims abstract 5
- 235000011187 glycerol Nutrition 0.000 claims description 16
- 238000004519 manufacturing process Methods 0.000 claims description 10
- OWVLYQRCCIEOPF-QHTZZOMLSA-L zinc;(2s)-5-oxopyrrolidine-2-carboxylate Chemical compound [Zn+2].[O-]C(=O)[C@@H]1CCC(=O)N1.[O-]C(=O)[C@@H]1CCC(=O)N1 OWVLYQRCCIEOPF-QHTZZOMLSA-L 0.000 claims description 10
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 7
- 229950008882 polysorbate Drugs 0.000 claims description 5
- 229920000136 polysorbate Polymers 0.000 claims description 5
- 239000002562 thickening agent Substances 0.000 claims description 5
- 229920001577 copolymer Polymers 0.000 claims description 3
- HLERILKGMXJNBU-UHFFFAOYSA-N norvaline betaine Chemical compound CCCC(C([O-])=O)[N+](C)(C)C HLERILKGMXJNBU-UHFFFAOYSA-N 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- 229940057950 sodium laureth sulfate Drugs 0.000 claims description 3
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 claims description 3
- 239000003205 fragrance Substances 0.000 claims description 2
- 241000219991 Lythraceae Species 0.000 claims 3
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 claims 1
- 244000294611 Punica granatum Species 0.000 abstract description 18
- 210000002374 sebum Anatomy 0.000 abstract description 13
- 230000028327 secretion Effects 0.000 abstract description 11
- 210000001732 sebaceous gland Anatomy 0.000 abstract description 7
- 238000000034 method Methods 0.000 abstract description 6
- 210000004761 scalp Anatomy 0.000 abstract description 5
- 208000002874 Acne Vulgaris Diseases 0.000 abstract description 4
- 206010000496 acne Diseases 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 239000004519 grease Substances 0.000 abstract description 3
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- 239000003921 oil Substances 0.000 description 34
- 210000003491 skin Anatomy 0.000 description 26
- 230000000694 effects Effects 0.000 description 19
- 241001122767 Theaceae Species 0.000 description 12
- 229960005150 glycerol Drugs 0.000 description 12
- 241000186427 Cutibacterium acnes Species 0.000 description 10
- 229940055019 propionibacterium acne Drugs 0.000 description 10
- 239000000243 solution Substances 0.000 description 9
- 230000006872 improvement Effects 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 5
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 3
- 208000035985 Body Odor Diseases 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 108090001005 Interleukin-6 Proteins 0.000 description 3
- 241000218378 Magnolia Species 0.000 description 3
- 206010040904 Skin odour abnormal Diseases 0.000 description 3
- 102000040945 Transcription factor Human genes 0.000 description 3
- 108091023040 Transcription factor Proteins 0.000 description 3
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 3
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 230000024203 complement activation Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000006197 histone deacetylation Effects 0.000 description 3
- 102000006495 integrins Human genes 0.000 description 3
- 108010044426 integrins Proteins 0.000 description 3
- 210000002510 keratinocyte Anatomy 0.000 description 3
- 210000003712 lysosome Anatomy 0.000 description 3
- 230000001868 lysosomic effect Effects 0.000 description 3
- 210000002540 macrophage Anatomy 0.000 description 3
- 210000000822 natural killer cell Anatomy 0.000 description 3
- 210000000440 neutrophil Anatomy 0.000 description 3
- 210000003463 organelle Anatomy 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000049539 Bolbitis heteroclita Species 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 102000029816 Collagenase Human genes 0.000 description 2
- 108060005980 Collagenase Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 description 2
- 206010039792 Seborrhoea Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 description 2
- 229940022757 asiaticoside Drugs 0.000 description 2
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 description 2
- 229960002424 collagenase Drugs 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- YLGYACDQVQQZSW-UHFFFAOYSA-N n,n-dimethylprop-2-enamide Chemical compound CN(C)C(=O)C=C YLGYACDQVQQZSW-UHFFFAOYSA-N 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 238000007447 staining method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229940104261 taurate Drugs 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 244000146462 Centella asiatica Species 0.000 description 1
- 235000004032 Centella asiatica Nutrition 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- 101000668058 Infectious salmon anemia virus (isolate Atlantic salmon/Norway/810/9/99) RNA-directed RNA polymerase catalytic subunit Proteins 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- QZXSMBBFBXPQHI-UHFFFAOYSA-N N-(dodecanoyl)ethanolamine Chemical compound CCCCCCCCCCCC(=O)NCCO QZXSMBBFBXPQHI-UHFFFAOYSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 239000005550 inflammation mediator Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 229920001197 polyacetylene Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000036555 skin type Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
Abstract
The invention discloses an oil control composition, a preparation method thereof and a skin care product and a shampoo containing the composition, wherein the oil control composition comprises the following components in percentage by weight except water: 18-22% of PCA zinc, 5-8% of tea extract, 9-13% of glycerol, 0.4-0.6% of 1, 2 hexanediol, 0.2-0.5% of phenoxyethanol, 3-8% of centella asiatica extract and 12-18% of 3BARK mixture; the 3BARK mixture comprises extracts of pericarp of mangosteen, BARK of Magnolia officinalis, and pericarp of pomegranate; the method comprises the following steps: (1) mixing water, tea extract and centella extract in proportion at 40-50 ℃, and homogenizing for 2-4 minutes to obtain a prefabricated solution for later use; (2) adding glycerol, stirring and homogenizing for 1-3 minutes; (3) adding PCA zinc, stirring and homogenizing for 2-4 min; (4) adding 1, 2 hexanediol and phenoxyethanol and stirring; the technical scheme has the advantages of inhibiting excessive sebum secretion of sebaceous glands, reducing greasiness of scalp and reducing acne caused by excessive grease.
Description
Technical Field
The invention belongs to the technical field of daily chemical products, and particularly relates to an Oil Control Composition (OCC), a preparation method thereof, and a skin care product and shampoo containing the OCC.
Background
Oily skin is a common skin type, for example, some people have greasy hair after washing for one or two days or become greasy on the face shortly after washing, which is caused by excessive sebum secretion from the sebaceous glands of the human body. Excessive sebum secretion may have some adverse effects on the skin of the human body, for example, excessive sebum secretion may make the hair or face of the human body always look greasy, which may affect interpersonal interaction between people; secondly, excessive secretion of sebum also often causes blockage of hair follicles of the scalp, so that the hair follicles are damaged, and then alopecia is caused; for another example, excessive sebum secretion can also cause Propionibacterium acnes to grow and multiply in the skin, thereby leading to acne and causing skin damage.
Therefore, there is a need for an oil control composition and a preparation method thereof, and a skin care product and a shampoo containing the composition, which can inhibit excessive sebum secretion from sebaceous glands, thereby reducing greasiness of scalp and acne caused by excessive grease.
Disclosure of Invention
In view of the above, the present invention provides an oil control composition (oil control cell) capable of inhibiting excessive sebum secretion from sebaceous glands, thereby reducing greasiness of scalp and acne caused by excessive grease, a preparation method thereof, and a skin care product and a shampoo containing the same.
In order to solve the technical problems, the technical scheme adopted by the invention is as follows:
the oil control composition comprises the following components in percentage by weight except water: 18-22% of PCA zinc, 5-8% of tea extract, 9-13% of glycerol, 0.4-0.6% of 1, 2 hexanediol, 0.2-0.5% of phenoxyethanol, 3-8% of centella asiatica extract and 12-18% of 3BARK mixture;
the 3BARK mixture comprises extracts of pericarp of mangosteen, BARK of Magnolia officinalis, and pericarp of pomegranate.
As a further improvement to the oil control composition, the oil control composition comprises the following components in percentage by weight, except water: zinc PCA 20%, tea extract 6%, glycerin 10%, 1, 2 hexanediol 0.5%, phenoxyethanol 0.5%, centella asiatica extract 3%, 3BARK mixture 15%.
As a further improvement to the oil control composition, in the 3BARK mixture, in terms of weight percentage, in addition to water, the content of the extract of the pericarp of the mangosteen is 0.1-0.4%, the content of the extract of the BARK of the mangnolia officinalis is 0.1-0.4%, and the content of the extract of the pericarp of the pomegranate is 0.3-0.7%.
As a further improvement to the oil control composition, 55-65% of dipropylene glycol and 205-9% of polysorbate are also included.
As a further improvement to the oil control composition, in the 3BARK mixture, in terms of weight percentage, in addition to water, the content of the extract of the pericarp of the mangnolia officinalis is 0.2%, the content of the extract of the BARK of the mangnolia officinalis is 0.3%, and the content of the extract of the pericarp of the pomegranate is 0.5%.
As a further improvement to the oil control composition, 60% dipropylene glycol and polysorbate-206% are also included.
A method for preparing an oil control composition, comprising the steps of:
(1) mixing water, tea extract and centella extract in proportion at 40-50 ℃, and homogenizing for 2-4 minutes to obtain a prefabricated solution for later use;
(2) adding glycerol into the solution obtained in the step (1) in proportion, and stirring and homogenizing for 1-3 minutes;
(3) adding PCA zinc into the solution obtained in the step (2) in proportion, and stirring and homogenizing for 2-4 minutes;
(4) and (4) adding 1, 2-hexanediol and phenoxyethanol into the solution obtained in the step (3) according to the proportion, and stirring.
A shampoo comprises, in weight percentage, 10% of the oil-control composition, 15% of sodium laureth sulfate, 0.2% of an aromatic, 0.6% of a preservative and 1.2% of a thickener, except water.
As a further improvement to the shampoo, it also included cocoyl propyl betaine 6%.
A skin care product comprises, in weight percentage, 6% of the oil control composition, 11% of glycerin and 3% of acryloyl dimethyl ammonium taurate/VP copolymer, wherein the oil control composition is not limited by water.
The technical effects generated by the invention are mainly reflected in that: is prepared by compounding zinc PCA, folium Camelliae sinensis extract, glycerol, 1, 2 hexanediol, phenoxyethanol, herba Centellae extract, and 3BARK mixture (mixture of zinc PCA and 3 BARK: (A. fern.))Garcinia mangostana) Pericarp extract, cortex Magnolia officinalisMagnolia officinalis) Bark extract, pomegranate (: (pomegranate)Punica granatum) Pericarp extract), and PCA zinc is involved in gene transcription by participating in histone deacetylation and zinc finger structural transcription factors; can maintain the functions of macrophage, neutrophil and natural killer cell and complement activity, stabilize the membrane of organelle, especially lysosome membrane, inhibit the expression of keratinocyte integrin, regulate the production of TNF-alpha and IL-6, wherein the mixture of PCA zinc and 3BARK can inhibit 5 alpha-reductase and reduce the production of inflammatory mediator. Furthermore, the PCA zinc is an important component of Natural Moisturizing Factor (NMF) inherent in the skin, can achieve the effect of astringing the skin after bacteriostasis, and simultaneously has the effects of moisturizing, relieving and replenishing water by 3bark in cooperation with the effect of relatively maintaining or prolonging the astringing skin, thereby achieving the effects of stabilizing the water-oil balance of the skin and reducing the generation of inflammation media.
Drawings
The foregoing and other objects, features and advantages of the invention will be apparent from the following more particular description of preferred embodiments of the invention, as illustrated in the accompanying drawings. Like reference numerals refer to like parts throughout the drawings, and the drawings are not intended to be drawn to scale in actual dimensions, emphasis instead being placed upon illustrating the principles of the invention.
FIG. 1 is a comparison graph of the results of testing the sebum content of the oil control composition of the present invention using the red oil 0 staining method;
FIG. 2 is an experimental graph of the inhibition zone of the oil-controlling composition of the present invention against Propionibacterium acnes;
FIG. 3 is a graph showing the comparison of oil control effect of the oil control composition applied to shampoo;
FIG. 4 is a comparative graph of skin care benefits of the oil control composition of the present invention applied to skin care products;
fig. 5 is a graph of user satisfaction with the oil control composition of the present invention in a skin care product.
Detailed Description
The technical solutions of the present invention are further described in detail with reference to specific examples so that those skilled in the art can better understand the present invention and can implement the present invention, but the examples are not intended to limit the present invention.
The embodiment of the invention provides an oil control composition, which comprises the following components in percentage by weight except for pure water: 18-22% of PCA zinc, 5-8% of tea extract, 9-13% of glycerol, 0.4-0.6% of 1, 2 hexanediol, 0.2-0.5% of phenoxyethanol, 3-8% of centella asiatica extract and 12-18% of 3BARK mixture; wherein the 3BARK mixture comprises extracts of pericarp of mangosteen, BARK of Magnolia officinalis, and pericarp of pomegranate. Furthermore, except water, in the 3BARK mixture, the content of the extracts of the pericarp of the mangnolia officinalis is 0.1-0.4%, the content of the extracts of the BARK of the mangnolia officinalis is 0.1-0.4%, and the content of the extracts of the pericarp of the pomegranate is 0.3-0.7%; also comprises 55-65% of dipropylene glycol and 205-9% of polysorbate.
Specifically, in the present invention, by mixing zinc PCA with 3bark (mangle: (Garcinia mangostana) Pericarp extract, cortex Magnolia officinalisMagnolia officinalis) Bark extract, pomegranate (: (pomegranate)Punica granatum) Pericarp extract), tea extract, glycerin, 1, 2 hexanediol, centella asiatica extract and phenoxyethanol; wherein, the anti-aging effect of the tea polyphenol in the tea extract is 18 times stronger than that of the vitamin E, and the efficiency of eliminating excessive free radicals harmful to human bodies by 1 mg of the tea polyphenol is equivalent to 9 micrograms of superoxide dismutase, which is greatly higher than other similar substances. The tea polyphenols have effects of blocking lipid peroxidation and removing active enzyme; centella asiatica is of UmbelliferaeThe centella asiatica extract contains triterpenes and compounds such as glycosides, polyacetylenes, volatile oil, flavonoids and alkaloids thereof, and has the main effect of total asiaticoside, wherein the total asiaticoside of the centella asiatica extract accounts for about 70 percent, is superior to other products sold in the market, and can effectively repair the skin barrier problem; PCA zinc is involved in gene transcription through participating in histone deacetylation and zinc finger structure transcription factors; can maintain the functions of macrophage, neutrophil and natural killer cell and complement activity, stabilize organelle membrane, especially lysosome membrane, inhibit the expression of keratinocyte integrin, regulate the production of TNF-alpha and IL-6, inhibit 5 alpha-reductase and reduce the production of inflammation mediator. Further, the mechanism of action of the present invention is 3 kinds as follows: 1. inhibition of sebum secretion: zinc inhibits 5 a-reductase activity. The 5 alpha-reductase catalyzes the production of Dihydrotestosterone (DHT), thereby stimulating the production and secretion of sebum by the sebaceous gland. 2. Absorbing body odor: one important cause of body odor is that short chain unsaturated fatty acids are oxidized and volatilize to form gases. Zinc PCA can form nonvolatile salt with these fatty acids, inhibit volatilization, and remove body odor. 3. Prevention of collagen hydrolysis: the activated protein-1 (AP-1) can promote the production of collagenase, hydrolyze collagen, inhibit the activity of AP-1, and protect collagen from hydrolysis by collagenase.
In a preferred embodiment, the composition comprises the following components in percentage by weight, except for water: zinc PCA 20%, tea extract 6%, glycerin 10%, 1, 2 hexanediol 0.5%, phenoxyethanol 0.5%, centella asiatica extract 3%, 3BARK mixture 15%.
Furthermore, except water, in the 3BARK mixture, the content of the extracts of the pericarp of the mangnolia officinalis is 0.1-0.4%, the content of the extracts of the BARK of the mangnolia officinalis is 0.1-0.4%, and the content of the extracts of the pericarp of the pomegranate is 0.3-0.7% by weight. Furthermore, in the 3BARK mixture, in addition to water, the content of the extract of the pericarp of the mangosteen is 0.2%, the content of the extract of the BARK of the magnolia officinalis is 0.3%, the content of the extract of the pericarp of the pomegranate is 0.5%, and the mixture further comprises 60% of dipropylene glycol and 206% of polysorbate.
The invention also provides a preparation method of the oil control composition, which comprises the following steps:
(1) setting the temperature of a stirrer at 40-50 ℃, wherein the temperature in the embodiment is 45 ℃, adding water, the tea extract and the centella asiatica extract into the stirrer according to the proportion, stirring at 35 revolutions per minute by the stirrer for 2-4 minutes to obtain a prefabricated solution, and stirring for 3 minutes in the embodiment for later use;
(2) adding glycerol into the solution obtained in the step (1) in proportion, and stirring and homogenizing for 1-3 minutes, wherein the stirring time is 2 minutes and the stirring speed is 35 revolutions per minute in the embodiment;
(3) adding PCA zinc into the solution obtained in the step (2) in proportion, and stirring and homogenizing for 2-4 minutes, wherein the stirring time is 3 minutes and the stirring speed is 35 revolutions per minute in the embodiment;
(4) and (4) adding 1, 2-hexanediol and phenoxyethanol into the solution obtained in the step (3) in proportion, and stirring to obtain the oil-controlling composition.
Experimental example:
in the formulation of this experimental example, in addition to pure water, zinc PCA 20%, tea extract 6%, glycerin 10%, 1, 2-hexanediol 0.5%, phenoxyethanol 0.5%, centella asiatica extract 3%, and 3BARK mixture 15%. Wherein, except water, the 3BARK mixture comprises 0.2% of the extract of the pericarp of the mangosteen, 0.3% of the extract of the BARK of the magnolia officinalis, 0.5% of the extract of the pericarp of the pomegranate, 60% of dipropylene glycol and 206% of polysorbate.
As shown in fig. 1, in the method for detecting sebum content by the oil red 0 staining method, i.e., in the sebaceous gland cell oil control model, two time periods of 24h and 48 h were observed on human sebaceous gland cells, and compared with control cells, red staining spots in the picture (left-right comparison) were significantly reduced, indicating that the above inventive formulation can effectively inhibit sebum synthesis.
As shown in fig. 2, a propionibacterium acnes zone model experiment was performed, propionibacterium acnes being a relatively slow growing, generally oxygen-tolerant, anaerobic gram-positive bacterium, the cell wall and the outer shell of which are almost different from those of other bacteria; propionibacterium acnes releases lipase, protease, and hyaluronidase, which can cause damage to skin tissue.
And (5) standard requirements are met.
On a culture dish of a microbial flora ATCC 11827, after a diluent is added to a flat plate by a perforation method and cultured for 72H, the diameter of a bacteriostatic circle is measured, and the sensitivity of the propionibacterium acnes to the formula is detected.
From the above data, it can be seen that: the oil control composition can effectively inhibit the breeding of propionibacterium acnes. Furthermore, the concentration of the diluent is between 1.5 and 10 percent, and the detection of the propionibacterium acnes can keep high sensitivity to the propionibacterium acnes; further, when the concentration of the dilution is below 1%, the sensitivity to Propionibacterium acnes begins to decrease until it is insensitive.
The embodiment of the invention also provides shampoo which comprises the following components, by weight, 10% of the oil control composition, 15% of sodium laureth sulfate, 0.2% of fragrance, 0.6% of preservative, 1.2% of thickening agent and 6% of cocoyl propyl betaine, wherein the components are calculated in percentage by weight except water. Further, the aromatic in this embodiment is lavender essence, although other types of aromatic can be used; the thickener in this example is sodium chloride, although other types of thickeners may be used, such as one or a combination of two or more of lauryl alcohol, myristyl alcohol, C12-15 alcohol, C12-16 alcohol, coconut diethanolamide, coconut monoethanolamide, and coconut monoisopropanolamide.
Examples of the experiments
Test requirements and methods
Testing the population: people 18-60 years old with oily hair; the health care product is suitable for both men and women and is healthy;
the test method comprises the following steps: scalp was washed normally, used once 2 days, and subjects assessed for head oil secretion by machine testing in the evaluation room at 24H after product use (D1), day 4 after product use (D4), day 10 after product use (D10) and day 15 after product use (D15) visits and recorded assessments;
a detection instrument: soft/fx, Italy.
As shown in fig. 3, the oil control efficiency of the product can be reflected by comparing the change of the oil control value a before and after use. The more the values at the different revisit time points are reduced compared to the baseline value before use (D0), indicating the better oil control of the product.
The embodiment of the invention also provides a skin care product which comprises 6 percent of the oil control composition, 11 percent of glycerin and 3 percent of acryloyl dimethyl ammonium taurate/VP copolymer in percentage by weight except water.
Examples of the experiments
The test method comprises the following steps: the skin condition of the skin care product in the experimental example after 1 month, the skin condition of the skin care product in the experimental example after 2 months and the skin condition of the skin care product in the experimental example after 3 months are shown in fig. 4, which are sequentially shown from left to right in 4 photographs of fig. 4.
Further, as shown in fig. 5, in order to verify whether the product meets the use requirements of different populations, 30 volunteers (age: 16-26 years old) are randomly selected for 1 month product test, and the volunteers are evaluated 1 month after cleaning face in the morning and at night and smearing for use, and the evaluation criteria are as follows: 1-3 are unsatisfactory; 4-5, the effect is general; the effect is better when the composition is divided into 6 to 8 parts; 9-10 are classified as being satisfactory. It can be seen from the data chart that 30 volunteers had a high satisfaction with the product effect after 1 month of use.
The technical effects generated by the invention are mainly reflected in that: is prepared by compounding zinc PCA, folium Camelliae sinensis extract, glycerol, 1, 2 hexanediol, phenoxyethanol, herba Centellae extract, and 3BARK mixture (mixture of zinc PCA and 3 BARK: (A. fern.))Garcinia mangostana) Pericarp extract, cortex Magnolia officinalisMagnolia officinalis) Bark extract, pomegranate (: (pomegranate)Punica granatum) Pericarp extract), and PCA zinc is involved in gene transcription by participating in histone deacetylation and zinc finger structural transcription factors; can maintain the functions of macrophage, neutrophil and natural killer cell and complement activity, stabilize the membrane of organelle, especially lysosome membrane, inhibit the expression of keratinocyte integrin, regulate the production of TNF-alpha and IL-6, wherein the mixture of PCA zinc and 3BARK can inhibit 5 alpha-reductase and reduce the production of inflammatory mediator. Furthermore, the PCA zinc is an important component of Natural Moisturizing Factor (NMF) inherent in the skin, can achieve the effect of astringing the skin after bacteriostasis, and simultaneously has the effects of moisturizing, relieving and replenishing water by 3bark in cooperation with the effect of relatively maintaining or prolonging the astringing skin, thereby achieving the effects of stabilizing the water-oil balance of the skin and reducing the generation of inflammation media.
The above description is only a preferred embodiment of the present invention, and not intended to limit the scope of the present invention, and all modifications of equivalent structures and equivalent processes, which are made by the present specification, or directly or indirectly applied to other related technical fields, are included in the scope of the present invention.
Claims (10)
1. The oil control composition is characterized by comprising the following components in percentage by weight except water: 18-22% of PCA zinc, 5-8% of tea extract, 9-13% of glycerol, 0.4-0.6% of 1, 2 hexanediol, 0.2-0.5% of phenoxyethanol, 3-8% of centella asiatica extract and 12-18% of 3BARK mixture;
the 3BARK mixture comprises extracts of pericarp of mangosteen, BARK of Magnolia officinalis, and pericarp of pomegranate.
2. The oil control composition of claim 1, comprising, in weight percent, in addition to water: zinc PCA 20%, tea extract 6%, glycerin 10%, 1, 2 hexanediol 0.5%, phenoxyethanol 0.5%, centella asiatica extract 3%, 3BARK mixture 15%.
3. The oil control composition of claim 1, wherein the 3BARK mixture comprises, in weight percent, in addition to water, 0.1-0.4% of the extract from the pericarp of mangnolia officinalis, 0.1-0.4% of the extract from the BARK of mangnolia officinalis, and 0.3-0.7% of the extract from the pericarp of pomegranate.
4. The oil control composition of claim 4, further comprising 55-65% dipropylene glycol and 205-9% polysorbate.
5. The oil control composition of claim 3 or 4, wherein the 3BARK mixture comprises, in weight percent, 0.2% of the extract from the pericarp of the mangnolia officinalis, 0.3% of the extract from the BARK of the mangnolia officinalis, and 0.5% of the extract from the pericarp of the pomegranate, excluding water.
6. The oil control composition of claim 5, further comprising 60% dipropylene glycol and polysorbate-206%.
7. A method of making the oil control composition of any one of claims 1 to 6, comprising the steps of:
(1) mixing water, tea extract and centella extract in proportion at 40-50 ℃, and homogenizing for 2-4 minutes to obtain a prefabricated solution for later use;
(2) adding glycerol into the solution obtained in the step (1) in proportion, and stirring and homogenizing for 1-3 minutes;
(3) adding PCA zinc into the solution obtained in the step (2) in proportion, and stirring and homogenizing for 2-4 minutes;
(4) and (4) adding 1, 2-hexanediol and phenoxyethanol into the solution obtained in the step (3) according to the proportion, and stirring.
8. A shampoo comprising, in weight percent, 10% of the oil control composition of any one of claims 1 to 5, 15% of sodium laureth sulfate, 0.2% of a fragrance, 0.6% of a preservative, and 1.2% of a thickener, excluding water.
9. The shampoo of claim 8 further comprising cocoyl propyl betaine 6%.
10. A skin care product comprising, in addition to water, 6% by weight of the oil control composition of any one of claims 1 to 5, 11% by weight of glycerin, and 3% by weight of an ammonium acryloyldimethyltaurate/VP copolymer.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111340294.9A CN114344183A (en) | 2021-11-12 | 2021-11-12 | Oil Control Composition (OCC), preparation method thereof, and skin care product and shampoo containing same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111340294.9A CN114344183A (en) | 2021-11-12 | 2021-11-12 | Oil Control Composition (OCC), preparation method thereof, and skin care product and shampoo containing same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114344183A true CN114344183A (en) | 2022-04-15 |
Family
ID=81095342
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111340294.9A Pending CN114344183A (en) | 2021-11-12 | 2021-11-12 | Oil Control Composition (OCC), preparation method thereof, and skin care product and shampoo containing same |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114344183A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116035955A (en) * | 2022-12-28 | 2023-05-02 | 寒霜籽(上海)生物科技有限公司 | Quick-absorption skin-care hair-care dual-purpose oil based on camellia seed oil |
-
2021
- 2021-11-12 CN CN202111340294.9A patent/CN114344183A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116035955A (en) * | 2022-12-28 | 2023-05-02 | 寒霜籽(上海)生物科技有限公司 | Quick-absorption skin-care hair-care dual-purpose oil based on camellia seed oil |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107213063B (en) | Fair and bright facial mask and preparation method thereof | |
| EP2883549B1 (en) | Antimicrobial composition comprising filobasidium-suppressing agent derived from natural substance | |
| CN109549863A (en) | A kind of lightening compositions and preparation method thereof | |
| CN108096055A (en) | A kind of face cleaning cream and preparation method thereof | |
| CN107982135A (en) | A kind of shampoo and preparation method thereof | |
| CN110151630A (en) | A kind of whitening and skin-protecting composition | |
| JP2012214392A (en) | Antioxidant agent, and antioxidant cosmetic | |
| CN109718138A (en) | Acne-eliminating cosmetic composition and its application | |
| CN111631965A (en) | Plant-derived facial mask with cleaning and makeup removing functions | |
| CN114344183A (en) | Oil Control Composition (OCC), preparation method thereof, and skin care product and shampoo containing same | |
| JP2015034131A (en) | Fermented fig extract, method for producing the same, and cosmetic in which fermented fig extract is blended | |
| JPH1129460A (en) | Cosmetic for sensitive skin | |
| JPH07258062A (en) | Cosmetic | |
| CN116509774B (en) | Anti-dandruff shampoo preparation containing sweet wormwood herb extract and preparation method thereof | |
| CN112263507B (en) | Composition for reducing skin irritation caused by surfactant and application thereof | |
| US20030031690A1 (en) | Cosmetic composition for preventing and treating acnes containing cryptotanshinone | |
| JP2001131049A (en) | Skin preparation for external use | |
| JP2006298814A (en) | Skin lotion for acne | |
| EP2747739B1 (en) | Dermocosmetic compositions based on a synergistic combination of colloidal silver and deoxyribonucleic acid | |
| JP2000072653A (en) | Use of fatty acid for cosmetic | |
| JPH07101836A (en) | Hair treating agent | |
| JP2018127407A (en) | Epidermis normalization agent as well as external preparations and cosmetics containing the same | |
| JP3083105B2 (en) | Cosmetics | |
| JP5985604B2 (en) | Use of (ethoxyhydroxyphenyl) alkyl ketones or ethoxyhydroxyalkylphenol compounds as antidandruff agents | |
| US20230201094A1 (en) | Personal Care Compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |